Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DM9ICSA)

Drug Name

1,2,3,4,6-penta-O-galloyl-D-glucopyranose Drug Info

Synonyms

D-Glucopyranose, pentakis(3,4,5-trihydroxybenzoate); 40410-94-4; 1,2,3,4,6-pentakis-o-(3,4,5-trihydroxybenzoyl)-d-glucopyranose; AC1L4RL6; SCHEMBL675693; AC1Q62I0; DTXSID00193426; 2,3,4,5,6-Pentagalloylglucose; BDBM175525; 3-O-Digalloyl-1,2,6-trigalloylglucose; 1,2,3,4,6-penta-O-galloyl--d-glucopyranose; US9120744, CDE-001 (or 073); 1-O,2-O,3-O,4-O,6-O-Pentagalloyl-D-glucopyranose; D-Glucose, 2,3,4,5,6-pentakis(3,4,5-trihydroxybenzoate); [(2R,3R,4S,5R)-3,4,5,6-tetrakis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 129651024
TTD Drug ID: DM9ICSA

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
PTPN1 messenger RNA (PTPN1 mRNA)	TTELIN2	PTN1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
PTPN1 messenger RNA (PTPN1 mRNA)	DTT	PTPN1	3.667	2.293	2.609	4.573

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
PTPN1 messenger RNA (PTPN1 mRNA)	DTT	PTPN1	9.44E-01	7.21E-03	0.08

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Bioactivity-guided isolation of 1,2,3,4,6-Penta-O-galloyl-D-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor. J Nat Prod. 2010 Sep 24;73(9):1578-81.